Form 8-K - Current report:
SEC Accession No. 0001445305-13-002363
Filing Date
2013-10-07
Accepted
2013-10-04 17:31:40
Documents
1
Period of Report
2013-10-04
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K a8k-october4acetadoteupdate.htm 8-K 30182
  Complete submission text file 0001445305-13-002363.txt   31186
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: 8-K | Act: 34 | File No.: 001-33637 | Film No.: 131137560
SIC: 2834 Pharmaceutical Preparations